New Jersey AG's Targets: J&J/DePuy, Biomet, Stryker, Medtronic And...
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/DePuy is the latest of four orthopedic device makers to acknowledge receipt of a subpoena from the New Jersey attorney general's office as part of an investigation into industry ties to clinical trial investigators
You may also be interested in...
Medtronic draws subpoena
Documents relating to the firm's cardiac rhythm management devices are subpoenaed by the Office of Inspector General for the Department of Health and Human Services in the district of California, Medtronic discloses in a quarterly financial report filed Dec. 9 with the Securities and Exchange Commission. Related documents include "revenue, sales, marketing and promotional documents, documents relating to reimbursement communications to customers pertaining to the devices, documents relating to scientific studies and registries pertaining to the devices, and documents relating to payments or items of value provided to customers," Medtronic explains. The firm says it will comply with the subpoena, which it received on Sept. 16. Medtronic received a separate subpoena in June from the New Jersey attorney general's office as part of an investigation into industry ties to clinical trial investigators (1"The Gray Sheet" Aug. 10, 2009)
Medtronic draws subpoena
Documents relating to the firm's cardiac rhythm management devices are subpoenaed by the Office of Inspector General for the Department of Health and Human Services in the district of California, Medtronic discloses in a quarterly financial report filed Dec. 9 with the Securities and Exchange Commission. Related documents include "revenue, sales, marketing and promotional documents, documents relating to reimbursement communications to customers pertaining to the devices, documents relating to scientific studies and registries pertaining to the devices, and documents relating to payments or items of value provided to customers," Medtronic explains. The firm says it will comply with the subpoena, which it received on Sept. 16. Medtronic received a separate subpoena in June from the New Jersey attorney general's office as part of an investigation into industry ties to clinical trial investigators (1"The Gray Sheet" Aug. 10, 2009)
New Jersey Attorney General Targets Industry Ties To Clinical Investigators
The attorney general of New Jersey is going after the device industry for failures to disclose possible financial conflicts of interest with clinical trial investigators, and wants FDA to strengthen its enforcement, as well